Related Experiment Videos
Level-adjusted perioperative risk of sacral amputations.
Clinton Devin1, Paul Y Chong, Ginger E Holt
1Department of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232-8774, USA.
Journal of Surgical Oncology
|August 11, 2006
Summary
Proximal sacral amputations above the S2 vertebral body are linked to significantly higher perioperative morbidity, including increased blood loss and hospital costs. These complex procedures should be reserved for patients with a strong potential for cure.
Area of Science:
- Oncology
- Surgical Oncology
- Orthopedic Surgery
Background:
- Sacral amputations above the S2 vertebral body present surgical challenges and are associated with long-term patient morbidity.
- Understanding the perioperative risks associated with the level of sacral resection is crucial for surgical planning and patient outcomes.
Purpose of the Study:
- To compare the perioperative morbidity of proximal sacral amputations (above S2) versus distal sacral amputations (below S2).
- To identify specific outcomes affected by the level of sacral resection in cancer surgery.
Main Methods:
- A retrospective evaluation of perioperative outcomes within 90 days of surgery for sacral amputations.
- Key outcome measures included estimated blood loss, intensive care unit (ICU) and hospital length of stay, hospital cost, and incidence of major and minor morbidities.
- Survival analyses were adjusted for resection level and tumor histology.
Main Results:
- Thirteen proximal and 14 distal sacral resections were analyzed.
- Proximal resections showed significantly higher median blood loss (4 L vs 1 L), ICU stay (4 days vs 0 days), hospital stay (19 days vs 8 days), and hospital cost ($28,800 vs $7,500).
- Major complications occurred in 85% of proximal resections versus 29% of distal resections (P = 0.011).
Conclusions:
- Tumor resections above the S2 vertebral body are associated with substantially increased perioperative morbidity.
- Proximal sacral osteotomies should be reserved for patients with a realistic potential for a complete cure.
- While resection level impacts morbidity, tumor type is a significant factor influencing patient survival.